Examine this issue in depth with your free download of the informative whitepaper Pursuing Excellence – Charting Industry’s Top Performances, which examines and dissects the challenges facing pharma’s major players and the prospects for the future of the biggest pharma companies and drugs on the market.
With your free download of Pursuing Excellence – Charting Industry’s Top Performances, you’ll discover:
- Which companies are spending the most on R&D in relation to their revenue
- Who leads the pack with the number of drugs currently in the pipeline, and which drugs are likely to go off-patent in the near future
- The biggest deal makers 2015 to 2016 in the oncology space, which currently accounts for 40% of all partnering activity and high-value transactions
- A rundown of the top 10 best-selling drugs of 2015 and their projected revenue trajectories for the coming years: which will continue to be winners and which will see significant losses
- Company prospects and future focus for the top 10 pharmaceutical companies operating today
- A look at pharma CEO compensation in 2015 and how anticipated future revenue growth affects their remuneration more than overall revenue